Setterwalls has assisted Coala-Life in connection with a fully guaranteed rights issue of SEK 150 million

Setterwalls has assisted Coala-Life Group AB (“Coala Life”) in connection with a fully guaranteed rights issue of SEK 150 million. Carnegie Investment Bank AB (publ) acted as Sole Global Coordinator in connection with the rights issue.

Coala Life is a medical device company founded in Sweden focusing on cloud-based cardiac and pulmonary diagnostics. The Company has developed and launched the Coala Heart Monitor – a multi-award winning, FDA-cleared and CE-approved product platform enabling long-term remote monitoring, analysis and algorithm-based diagnostics of heart and auscultation of lungs in real-time.